Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Feb;82(4):818–822. doi: 10.1054/bjoc.1999.1005

Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes

N Soufir 1,1, B Bressac-de Paillerets 1, L Desjardins 2, C Lévy 2, J Bombled 1, I Gorin 3, P Schlienger 4, D Stoppa-Lyonnet 5
PMCID: PMC2374387  PMID: 10732752

Abstract

In familial cutaneous malignant melanoma (CMM), disruption of the retinoblastoma (pRB) pathway frequently occurs through inactivating mutations in the p16 (p16INK4A/CDKN2A/MTS1) gene or activating mutations in the G1-specific cyclin dependent kinase 4 gene (CDK4). Uveal malignant melanoma (UMM) also occurs in a familial setting, or sometimes in association with familial or sporadic CMM. Molecular studies of sporadic UMM have revealed somatic deletions covering the INK4A-ARF locus (encoding P16INK4Aand P14ARF) in a large proportion of tumours. We hypothesized that germline mutations in the p16INK4A, p14ARFor CDK4 genes might contribute to some cases of familial UMM, or to some cases of UMM associated with another melanoma. Out of 155 patients treated at the Institut Curie for UMM between 1994 and 1997, and interviewed about their personal and familial history of melanoma, we identified seven patients with a relative affected with UMM (n = 6) or CMM (n = 1), and two patients who have had, in addition to UMM, a personal history of second melanoma, UMM (n = 1), or CMM (n = 1). We screened by polymerase chain reaction single-strand conformation polymorphism the entire coding sequence of the INK4A-ARF locus (exon 1α from p16INK4A, exon 1β from p14ARF, and exons 2 and 3, common to both genes), as well as the exons 2, 5 and 8 of the CDK4 gene, coding for the functional domains involved in p16 and/or cyclin D1 binding. A previously reported polymorphism in exon 3 of the INK4A-ARF locus was found in one patient affected with bilateral UMM, but no germline mutations were detected, either in the p16INK4A, p14ARFor CDK4 genes. Our data support the involvement of other genes in predisposition to uveal melanoma. © 2000 Cancer Research Campaign

Keywords: uveal melanoma, germline mutation, P16INK4A, P14ARF, cdk4

Full Text

The Full Text of this article is available as a PDF (63.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitken J., Welch J., Duffy D., Milligan A., Green A., Martin N., Hayward N. CDKN2A variants in a population-based sample of Queensland families with melanoma. J Natl Cancer Inst. 1999 Mar 3;91(5):446–452. doi: 10.1093/jnci/91.5.446. [DOI] [PubMed] [Google Scholar]
  2. Bahuau M., Vidaud D., Jenkins R. B., Bièche I., Kimmel D. W., Assouline B., Smith J. S., Alderete B., Cayuela J. M., Harpey J. P. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors. Cancer Res. 1998 Jun 1;58(11):2298–2303. [PubMed] [Google Scholar]
  3. Bale S. J., Dracopoli N. C., Tucker M. A., Clark W. H., Jr, Fraser M. C., Stanger B. Z., Green P., Donis-Keller H., Housman D. E., Greene M. H. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med. 1989 May 25;320(21):1367–1372. doi: 10.1056/NEJM198905253202102. [DOI] [PubMed] [Google Scholar]
  4. Bataille V., Pinney E., Hungerford J. L., Cuzick J., Bishop D. T., Newton J. A. Five cases of coexistent primary ocular and cutaneous melanoma. Arch Dermatol. 1993 Feb;129(2):198–201. [PubMed] [Google Scholar]
  5. Byeon I. J., Li J., Ericson K., Selby T. L., Tevelev A., Kim H. J., O'Maille P., Tsai M. D. Tumor suppressor p16INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4. Mol Cell. 1998 Feb;1(3):421–431. doi: 10.1016/s1097-2765(00)80042-8. [DOI] [PubMed] [Google Scholar]
  6. Canning C. R., Hungerford J. Familial uveal melanoma. Br J Ophthalmol. 1988 Apr;72(4):241–243. doi: 10.1136/bjo.72.4.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cannon-Albright L. A., Goldgar D. E., Meyer L. J., Lewis C. M., Anderson D. E., Fountain J. W., Hegi M. E., Wiseman R. W., Petty E. M., Bale A. E. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science. 1992 Nov 13;258(5085):1148–1152. doi: 10.1126/science.1439824. [DOI] [PubMed] [Google Scholar]
  8. Chaubert P., Shaw P., Pillet N. Informative MspI polymorphism adjacent to exon 3 of the p16INK4 (MTS1) gene. Mol Cell Probes. 1996 Dec;10(6):467–468. doi: 10.1006/mcpr.1996.0064. [DOI] [PubMed] [Google Scholar]
  9. Coleman K. G., Wautlet B. S., Morrissey D., Mulheron J., Sedman S. A., Brinkley P., Price S., Webster K. R. Identification of CDK4 sequences involved in cyclin D1 and p16 binding. J Biol Chem. 1997 Jul 25;272(30):18869–18874. doi: 10.1074/jbc.272.30.18869. [DOI] [PubMed] [Google Scholar]
  10. Dracopoli N. C., Fountain J. W. CDKN2 mutations in melanoma. Cancer Surv. 1996;26:115–132. [PubMed] [Google Scholar]
  11. Easton D. F., Steele L., Fields P., Ormiston W., Averill D., Daly P. A., McManus R., Neuhausen S. L., Ford D., Wooster R. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet. 1997 Jul;61(1):120–128. doi: 10.1086/513891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goldstein A. M., Dracopoli N. C., Ho E. C., Fraser M. C., Kearns K. S., Bale S. J., McBride O. W., Clark W. H., Jr, Tucker M. A. Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity. Am J Hum Genet. 1993 Mar;52(3):537–550. [PMC free article] [PubMed] [Google Scholar]
  13. Kamb A., Shattuck-Eidens D., Eeles R., Liu Q., Gruis N. A., Ding W., Hussey C., Tran T., Miki Y., Weaver-Feldhaus J. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet. 1994 Sep;8(1):23–26. doi: 10.1038/ng0994-22. [DOI] [PubMed] [Google Scholar]
  14. Kamijo T., Weber J. D., Zambetti G., Zindy F., Roussel M. F., Sherr C. J. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8292–8297. doi: 10.1073/pnas.95.14.8292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kumar R., Sauroja I., Punnonen K., Jansen C., Hemminki K. Selective deletion of exon 1 beta of the p19ARF gene in metastatic melanoma cell lines. Genes Chromosomes Cancer. 1998 Nov;23(3):273–277. doi: 10.1002/(sici)1098-2264(199811)23:3<273::aid-gcc11>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  16. Liu L., Dilworth D., Gao L., Monzon J., Summers A., Lassam N., Hogg D. Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma. Nat Genet. 1999 Jan;21(1):128–132. doi: 10.1038/5082. [DOI] [PubMed] [Google Scholar]
  17. Liu L., Goldstein A. M., Tucker M. A., Brill H., Gruis N. A., Hogg D., Lassam N. J. Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF. Genes Chromosomes Cancer. 1997 May;19(1):52–54. [PubMed] [Google Scholar]
  18. Lynch H. T., Anderson D. E., Krush A. J. Heredity and intraocular malignant melanoma. Study of two families and review of forty-five cases. Cancer. 1968 Jan;21(1):119–125. doi: 10.1002/1097-0142(196801)21:1<119::aid-cncr2820210118>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  19. Merbs S. L., Sidransky D. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma. Invest Ophthalmol Vis Sci. 1999 Mar;40(3):779–783. [PubMed] [Google Scholar]
  20. Mouriaux F., Casagrande F., Pillaire M. J., Manenti S., Malecaze F., Darbon J. M. Differential expression of G1 cyclins and cyclin-dependent kinase inhibitors in normal and transformed melanocytes. Invest Ophthalmol Vis Sci. 1998 May;39(6):876–884. [PubMed] [Google Scholar]
  21. Newton Bishop J. A., Bataille V., Pinney E., Bishop D. T. Family studies in melanoma: identification of the atypical mole syndrome (AMS) phenotype. Melanoma Res. 1994 Aug;4(4):199–206. doi: 10.1097/00008390-199408000-00001. [DOI] [PubMed] [Google Scholar]
  22. Ohta M., Nagai H., Shimizu M., Rasio D., Berd D., Mastrangelo M., Singh A. D., Shields J. A., Shields C. L., Croce C. M. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Res. 1994 Oct 15;54(20):5269–5272. [PubMed] [Google Scholar]
  23. Prescher G., Bornfeld N., Becher R. Two subclones in a case of uveal melanoma. Relevance of monosomy 3 and multiplication of chromosome 8q. Cancer Genet Cytogenet. 1994 Oct 15;77(2):144–146. doi: 10.1016/0165-4608(94)90230-5. [DOI] [PubMed] [Google Scholar]
  24. Puig S., Ruiz A., Lázaro C., Castel T., Lynch M., Palou J., Vilalta A., Weissenbach J., Mascaro J. M., Estivill X. Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene. Am J Hum Genet. 1995 Aug;57(2):395–402. [PMC free article] [PubMed] [Google Scholar]
  25. Serrano M., Hannon G. J., Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993 Dec 16;366(6456):704–707. doi: 10.1038/366704a0. [DOI] [PubMed] [Google Scholar]
  26. Singh A. D., Croce C. M., Wary K. K., Shields J. A., Donoso L. A., Shields C. L., Huebner K., Ohta M. Familial uveal melanoma: absence of germline mutations involving the cyclin-dependent kinase-4 inhibitor gene (p16). Ophthalmic Genet. 1996 Mar;17(1):39–40. doi: 10.3109/13816819609057868. [DOI] [PubMed] [Google Scholar]
  27. Singh A. D., Shields C. L., De Potter P., Shields J. A., Trock B., Cater J., Pastore D. Familial uveal melanoma. Clinical observations on 56 patients. Arch Ophthalmol. 1996 Apr;114(4):392–399. doi: 10.1001/archopht.1996.01100130388005. [DOI] [PubMed] [Google Scholar]
  28. Singh A. D., Wang M. X., Donoso L. A., Shields C. L., Potter P. D., Shields J. A., Elston R. C., Fijal B. Familial uveal melanoma, III. Is the occurrence of familial uveal melanoma coincidental?. Arch Ophthalmol. 1996 Sep;114(9):1101–1104. doi: 10.1001/archopht.1996.01100140303008. [DOI] [PubMed] [Google Scholar]
  29. Sinilnikova O. M., Egan K. M., Quinn J. L., Boutrand L., Lenoir G. M., Stoppa-Lyonnet D., Desjardins L., Levy C., Goldgar D., Gragoudas E. S. Germline brca2 sequence variants in patients with ocular melanoma. Int J Cancer. 1999 Jul 30;82(3):325–328. doi: 10.1002/(sici)1097-0215(19990730)82:3<325::aid-ijc3>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  30. Soufir N., Avril M. F., Chompret A., Demenais F., Bombled J., Spatz A., Stoppa-Lyonnet D., Bénard J., Bressac-de Paillerets B. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. Hum Mol Genet. 1998 Feb;7(2):209–216. doi: 10.1093/hmg/7.2.209. [DOI] [PubMed] [Google Scholar]
  31. Speicher M. R., Prescher G., du Manoir S., Jauch A., Horsthemke B., Bornfeld N., Becher R., Cremer T. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Cancer Res. 1994 Jul 15;54(14):3817–3823. [PubMed] [Google Scholar]
  32. Stott F. J., Bates S., James M. C., McConnell B. B., Starborg M., Brookes S., Palmero I., Ryan K., Hara E., Vousden K. H. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 1998 Sep 1;17(17):5001–5014. doi: 10.1093/emboj/17.17.5001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tsao H., Benoit E., Sober A. J., Thiele C., Haluska F. G. Novel mutations in the p16/CDKN2A binding region of the cyclin-dependent kinase-4 gene. Cancer Res. 1998 Jan 1;58(1):109–113. [PubMed] [Google Scholar]
  34. Wang X., Egan K. M., Gragoudas E. S., Kelsey K. T. Constitutional alterations in p16 in patients with uveal melanoma. Melanoma Res. 1996 Dec;6(6):405–410. doi: 10.1097/00008390-199612000-00001. [DOI] [PubMed] [Google Scholar]
  35. Zuo L., Weger J., Yang Q., Goldstein A. M., Tucker M. A., Walker G. J., Hayward N., Dracopoli N. C. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet. 1996 Jan;12(1):97–99. doi: 10.1038/ng0196-97. [DOI] [PubMed] [Google Scholar]
  36. van Hees C. L., Jager M. J., Bleeker J. C., Kemme H., Bergman W. Occurrence of cutaneous and uveal melanoma in patients with uveal melanoma and their first degree relatives. Melanoma Res. 1998 Apr;8(2):175–180. doi: 10.1097/00008390-199804000-00013. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES